Subcutaneous immunotherapy in patients with eosinophilic esophagitis

Ann Allergy Asthma Immunol. 2019 May;122(5):532-533.e3. doi: 10.1016/j.anai.2019.02.022. Epub 2019 Mar 2.

Authors

Benjamin S Robey¹, Swathi Eluri¹, Craig C Reed¹, Maya R Jerath², Michelle L Hernandez², Scott P Commins², Evan S Dellon³

Affiliations

¹ Center for Esophageal Diseases and Swallowing, Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
² Division of Allergy and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.
³ Center for Esophageal Diseases and Swallowing, Center for Gastrointestinal Biology and Disease, Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina. Electronic address: edellon@med.unc.edu.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Allergens / administration & dosage*
Allergens / chemistry
Allergens / immunology
Alternaria / chemistry
Alternaria / immunology
Animals
Child
Dander / chemistry
Dander / immunology
Eosinophilic Esophagitis / chemically induced
Eosinophilic Esophagitis / immunology
Eosinophilic Esophagitis / pathology
Eosinophilic Esophagitis / therapy*
Eosinophils / drug effects*
Eosinophils / immunology
Eosinophils / pathology
Female
Humans
Immunoglobulin E / biosynthesis
Immunotherapy / methods*
Injections, Subcutaneous
Male
Middle Aged
Pollen / chemistry
Pollen / immunology
Pyroglyphidae / chemistry
Pyroglyphidae / immunology
Retrospective Studies

Substances

Allergens
Immunoglobulin E

Grants and funding